Heartflow (HTFL) Receivables - Other (2024 - 2025)
Heartflow's quarterly Receivables - Other came in at $814000.0 in Q4 2025, up 41.81% year-on-year from $574000.0 in Q4 2024, and up 263.39% quarter-over-quarter from $224000.0 in Q3 2025.
Heartflow has reported Receivables - Other for 2 years, with the latest figure at $814000.0 in Q4 2025.
- For the quarter ending Q4 2025, Receivables - Other rose 41.81% year-over-year to $814000.0; the trailing twelve-month figure through Dec 2025 stood at $814000.0 (up 41.81% YoY), and the FY2025 full-year result was $814000.0, up 41.81% from the prior year.
- Receivables - Other for Q4 2025 stood at $814000.0, up from $224000.0 in the prior quarter.
- The five-year high for Receivables - Other was $820000.0 in Q2 2025, with the low at $224000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 814,000.00 |
| Dec 31, 2025 | 814,000.00 |
| Sep 30, 2025 | 224,000.00 |
| Sep 30, 2025 | 224,000.00 |
| Jun 30, 2025 | 820,000.00 |
| Jun 30, 2025 | 820,000.00 |
| Dec 31, 2024 | 574,000.00 |
| Dec 31, 2024 | 574,000.00 |